What if our mucous membranes held a key to slowing HIV? IgA antibodies in our mucous membranes train the immune system to better fight HIV.

Published on
Research

In an article published in Mucosal Immunology, scientists show that IgA antibodies present in mucous membranes play a key role against HIV. By triggering the destruction of infected cells, which then allows the activation of killer lymphocytes, they strengthen the cooperation between innate and adaptive immunity, paving the way for new strategies to limit the spread of the virus.

IgA antibodies: a first line of defense against infections

Mucosal IgA antibodies represent our body's first line of defense against infections that attack mucous membranes (such as those of the nose, mouth, lungs, or genital tract). Each antibody has a region called the Fab region, which varies from one antibody to another and allows it to recognize specific antigens.
IgA antibodies can also fight viruses thanks to another region common to all antibodies: the Fc domain. This domain destroys infected cells through a mechanism called Antibody-Dependent Cellular Phagocytosis (ADCP). This process is carried out by certain cells of the innate immune system, such as monocytes, which engulf infected cells.

Previous studies have shown that injecting anti-HIV-1 IgG antibodies (a technique called passive immunization) could protect non-human primates. This protection depended on the action of CD8+ T lymphocytes, killer cells of the immune system, likely thanks to the ADCP carried out by these IgGs.

A study that reveals the key role of IgA against HIV

In a study published in the journal Mucosal Immunology, researchers compared the effects of phagocytosis of HIV-1-infected cells when triggered by virus-specific antibodies, either in the IgA or IgG form. They discovered that phagocytosis mediated by IgA abundant in the mucous membranes, not only destroyed infected cells but also allowed to present viral antigens to CD8+ T lymphocytes and activated their cytotoxic function (their ability to kill infected cells). In contrast, IgG antibodies, more prevalent in the blood, did not produce this effect.
Furthermore, after binding to IgA and triggering phagocytosis of infected cells, monocytes reprogram themselves into activated macrophages. These macrophages exhibit a mixture of pro-inflammatory and anti-inflammatory properties and secrete pro-inflammatory chemokines (molecules that attract other immune cells).
IgA-mediated ADCP also makes monocytes more reactive to a new bacterial infection: they produce more cytokines such as IL-6 and TNFα. This phenomenon is a sign of trained immunity, a recent form of memory in the innate immune system, which allows it to better respond to future attacks.
All these observations show that there is a close link between adaptive (specific) immunity initiated by IgA and innate (natural) immunity.

This discovery opens the way to new strategies to prevent the spread of HIV, by exploiting the protective role of IgA antibodies and their ability to activate both the natural and specific defenses of our body.

IgA protects mucous membranes from HIV-1 infection by establishing a bridge between innate and cellular adaptative immunity. ©Morgane Bomsel

Reference

IgA-dependent cell phagocytosis of HIV-infected cells elicits cross-presentation to CD8+T cells and immune memory in effector monocytes. Andrea Cottignies-Calamarte, Annouk Dauvilliers, Lucie Adoux, Benjamin Saint-Pierre, Franck Letourneur, Sylvain Cardinaud, Daniela Tudor, Morgane Bomsel. Mucosal Immunology, Published online October 28, 2025. DOI: 10.1016/j.mucimm.2025.09.004

Contact

Morgane Bomsel

Contact by email